Work

Abstract B025: The innate immune checkpoint TREX1 is a safe, effective, and druggable target for cancer immunotherapy

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b025

Authors: Cong Xing, Nan Yan

Institution: The University of Texas Southwestern Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444738

Cites:

Cited by:

Related to: